First Time Loading...
P

Panagene Inc
KOSDAQ:046210

Watchlist Manager
Panagene Inc
KOSDAQ:046210
Watchlist
Price: 4 070 KRW -0.25% Market Closed
Updated: May 3, 2024

Intrinsic Value

PANAGENE Inc. engages in the molecular diagnostics business. [ Read More ]

The intrinsic value of one Panagene Inc stock under the Base Case scenario is 1 912.78 KRW. Compared to the current market price of 4 070 KRW, Panagene Inc is Overvalued by 53%.

Key Points:
Intrinsic Value
Base Case
1 912.78 KRW
Overvaluation 53%
Intrinsic Value
Price
P
Worst Case
Base Case
Best Case

Valuation Backtest
Panagene Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling Panagene Inc stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Panagene Inc

Provide an overview of the primary business activities
of Panagene Inc.

What unique competitive advantages
does Panagene Inc hold over its rivals?

What risks and challenges
does Panagene Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Panagene Inc.

Provide P/S
for Panagene Inc.

Provide P/E
for Panagene Inc.

Provide P/OCF
for Panagene Inc.

Provide P/FCFE
for Panagene Inc.

Provide P/B
for Panagene Inc.

Provide EV/S
for Panagene Inc.

Provide EV/GP
for Panagene Inc.

Provide EV/EBITDA
for Panagene Inc.

Provide EV/EBIT
for Panagene Inc.

Provide EV/OCF
for Panagene Inc.

Provide EV/FCFF
for Panagene Inc.

Provide EV/IC
for Panagene Inc.

What are the Revenue projections
for Panagene Inc?

How accurate were the past Revenue estimates
for Panagene Inc?

What are the Net Income projections
for Panagene Inc?

How accurate were the past Net Income estimates
for Panagene Inc?

What are the EPS projections
for Panagene Inc?

How accurate were the past EPS estimates
for Panagene Inc?

What are the EBIT projections
for Panagene Inc?

How accurate were the past EBIT estimates
for Panagene Inc?

Compare the revenue forecasts
for Panagene Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Panagene Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Panagene Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Panagene Inc compared to its peers.

Compare the P/E ratios
of Panagene Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Panagene Inc with its peers.

Analyze the financial leverage
of Panagene Inc compared to its main competitors.

Show all profitability ratios
for Panagene Inc.

Provide ROE
for Panagene Inc.

Provide ROA
for Panagene Inc.

Provide ROIC
for Panagene Inc.

Provide ROCE
for Panagene Inc.

Provide Gross Margin
for Panagene Inc.

Provide Operating Margin
for Panagene Inc.

Provide Net Margin
for Panagene Inc.

Provide FCF Margin
for Panagene Inc.

Show all solvency ratios
for Panagene Inc.

Provide D/E Ratio
for Panagene Inc.

Provide D/A Ratio
for Panagene Inc.

Provide Interest Coverage Ratio
for Panagene Inc.

Provide Altman Z-Score Ratio
for Panagene Inc.

Provide Quick Ratio
for Panagene Inc.

Provide Current Ratio
for Panagene Inc.

Provide Cash Ratio
for Panagene Inc.

What is the historical Revenue growth
over the last 5 years for Panagene Inc?

What is the historical Net Income growth
over the last 5 years for Panagene Inc?

What is the current Free Cash Flow
of Panagene Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Panagene Inc.

Financials

Balance Sheet Decomposition
Panagene Inc

Current Assets 82.9B
Cash & Short-Term Investments 76.9B
Receivables 3B
Other Current Assets 3B
Non-Current Assets 8B
PP&E 7.3B
Intangibles 286.2m
Other Non-Current Assets 389.8m
Current Liabilities 27.1B
Accounts Payable 431.6m
Accrued Liabilities 161.2m
Other Current Liabilities 26.5B
Non-Current Liabilities 206.4m
Long-Term Debt 89.4m
Other Non-Current Liabilities 117m
Efficiency

Earnings Waterfall
Panagene Inc

Revenue
12.3B KRW
Cost of Revenue
-4B KRW
Gross Profit
8.2B KRW
Operating Expenses
-10.1B KRW
Operating Income
-1.8B KRW
Other Expenses
-3B KRW
Net Income
-4.8B KRW

Free Cash Flow Analysis
Panagene Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

Profitability Score
Profitability Due Diligence

Panagene Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Negative Free Cash Flow
Positive 3-Year Average ROIC
Negative Net Income
50/100
Profitability
Score

Panagene Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Panagene Inc's solvency score is 62/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
62/100
Solvency
Score

Panagene Inc's solvency score is 62/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Panagene Inc

There are no price targets for Panagene Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
Panagene Inc

1M 1M
-8%
6M 6M
+11%
1Y 1Y
+4%
3Y 3Y
-24%
5Y 5Y
-10%
10Y 10Y
+8%
Annual Price Range
4 070
52w Low
3 040
52w High
5 810
Price Metrics
Average Annual Return 11.65%
Standard Deviation of Annual Returns 64.86%
Max Drawdown -74%
Shares Statistics
Market Capitalization 166.9B KRW
Shares Outstanding 41 014 500
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Panagene Inc

Country

Korea

Industry

Biotechnology

Market Cap

166.9B KRW

Dividend Yield

0%

Description

PANAGENE Inc. engages in the molecular diagnostics business. The company is headquartered in Daejeon, Daejeon and currently employs 71 full-time employees. The company went IPO on 2000-08-16. The firm develops selective deoxyribonucleic acid (DNA) amplification technology and detection technology which used in the drug susceptibity testing, single nucleotide sequence variation inspection, infectious diseases hospital inspection and other DNA relates diseases inspection. The Company’s customs mainly include DAKO, AdvanDx, Abbott, LSI Medience Corporation and others.

Contact

DAEJEON
DAEJEON
54, Techno 10-ro, Yuseong-gu
+82428619295
http://www.panagene.com

IPO

2000-08-16

Employees

71

Officers

Managing Director
Tae-Sung Kim
Chief Exec. Officer and Pres
Sung-Ki Kim
Head of Marketing
Dal-Soo Kim
Head of Laboratory and Managing Director
Hee-Kyung Park
Head of Information management
Won-Yong Go
Exec.
Jin-Haeng Lee

See Also

Discover More
What is the Intrinsic Value of one Panagene Inc stock?

The intrinsic value of one Panagene Inc stock under the Base Case scenario is 1 912.78 KRW.

Is Panagene Inc stock undervalued or overvalued?

Compared to the current market price of 4 070 KRW, Panagene Inc is Overvalued by 53%.